ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
21/03/2025
Voltar para busca
Dado oficial do USPTO
SINEUP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
27/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
22/01/2021
Data de registro
31/01/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/01/2023
Última transação
27/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
GB
Examinador
JANSON, ANDREW
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Harness Therapeutics Limited
Transine Therapeutics Limited
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
chemical preparations for scientific purposesother than for medical or veterinary use; chemicals for research usenucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research usenucleic acid sequences for laboratory usenucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNAreagents for scientific purposesother than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNAenzymes for scientific and research purposes; molecular biology research tools in the nature of biologicalchemical and biochemical reagents for research use
Classe 5
Pharmaceutical preparations for the treatment and prevention of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditionshearing losshematologic diseasesimmune response disordersneurological disordersrespiratory diseasesfibrosishepatic diseasesrenal diseasesdiseases of the pancreasmetabolic diseasesgenetic conditionscancerinfectious diseases and cardiovascular diseases; biologicalchemical and biochemical reagentsDNA and RNA sequences and gene editing enzymesall for medical use; DNA and RNA products for medical usenucleic acid sequences for medical purposes; therapeutic DNA and RNAnucleic acid sequences for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/03/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/05/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/05/2023
FIMP
FINAL DISPOSITION PROCESSED
04/05/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
31/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/11/2022
PUBO
PUBLISHED FOR OPPOSITION
15/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
14/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/10/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/10/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/09/2022
DOCK
ASSIGNED TO EXAMINER
07/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/08/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/08/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
20/08/2022
DOCK
ASSIGNED TO EXAMINER
15/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
14/04/2022
GNFR
FINAL REFUSAL E-MAILED
14/04/2022
CNFR
FINAL REFUSAL WRITTEN
14/04/2022
DOCK
ASSIGNED TO EXAMINER
14/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/02/2022
RFNT
REFUSAL PROCESSED BY IB
11/09/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/08/2021
RFRR
REFUSAL PROCESSED BY MPU
25/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/08/2021
CNRT
NON-FINAL ACTION WRITTEN
11/08/2021
DOCK
ASSIGNED TO EXAMINER
09/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
02/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/03/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/03/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SINEUP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.